Trevena
TRVN
#11301
Rank
NZ$0.01 M
Marketcap
NZ$0.02138
Share price
0.00%
Change (1 day)
-38.81%
Change (1 year)

Market capitalization of Trevena (TRVN)

Market cap: NZ$0.01 Million

As of October 2026 Trevena has a market cap of NZ$0.01 Million. This makes Trevena the world's 11301th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Trevena from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.01 M3.2%
2025NZ$0.01 M-99.36%
2024NZ$2.81 M-83.73%
2023NZ$17.32 M10.69%
2022NZ$15.65 M-88.84%
2021NZ$0.14 B-70.43%
2020NZ$0.47 B303.4%
2019NZ$0.11 B122.9%
2018NZ$52.77 M-62.4%
2017NZ$0.14 B-68.41%
2016NZ$0.44 B-43%
2015NZ$0.77 B160.23%
2014NZ$0.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$399.66 B 2,163,936,182.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$640.09 B 3,465,703,547.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.81 B 4,427,600.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$15.58 B 84,379,673.47%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$25.97 M 140,555.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$14.45 M 78,149.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
NZ$10.98 B 59,482,034.72%๐Ÿ‡บ๐Ÿ‡ธ USA